Severe chronic refractory immune thrombocytopenic purpura during childhood: A survey of physician management

Pediatric Blood and Cancer

Volumn 51, Issue 4, 2008, Pages 513-516

  Neunert, Cindy E ^a,b   Bright, Brianna C ^c   Buchanan, George R ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Immune thrombocytopenic purpura; Rituximab; Splenectomy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN DERIVATIVE; RHESUS D ANTIBODY; RITUXIMAB; STEROID; VINCRISTINE;

ARTICLE; CASE REPORT; CHRONIC DISEASE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SPLENECTOMY; TREATMENT INDICATION; TREATMENT RESPONSE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; HUMANS; PHYSICIANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 50249155246     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21621     Document Type: Article

References (22)

1. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
2. Minkov M. Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood. Pediatr Blood Cancer 2006;47:734-736.
3. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2000;22:148-153.
4. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 1995;122:187-188.
5. Blanchette VS, Price V. Childhood chronic immune thrombocytopenic purpura: Unresolved issues. J Pediatr Hematol Oncol 2003;25:S28-S33.
6. Bennett CM, Rogers ZR, Kinnamon DD, et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006;107:2639-2642.
7. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-596.
8. Najean Y, Rain JD, Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies. Br J Haematol 1997; 97:547-550.
9. Choi CW, Kim BS, Seo JH, et al. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol 2001;66:197-202.
10. Holt D, Brown J, Terrill K, et al. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 2003;111:87-90.
11. Law C, Marcaccio M, Tam P, et al. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;336:1494-1498.
12. Schneider P, Wehmeier A, Schneider W. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;337:1087-1088, author reply 1089.
13. Fabris F, Cordiano I, Girolami A. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;337:1088-1089.
14. Ruivard M, Caulier MT, Vantelon JM, et al. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol 1999;105:1130-1132.
15. Bussel JB, Kaufmann CP, Ware RE, et al. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol 2001;67:27-33.
16. Kuhne T, Blanchette V, Buchanan GR, et al. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007;49:829-834.
17. Wang J, Wiley JM, Luddy R, et al. Chronic immune thrombocytopenic purpura in children: Assessment of rituximab treatment. J Pediatr 2005;146:217-221.
18. Taube T, Schmid H, Reinhard H, et al. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica 2005;90:281-283.
19. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet 2008;371:395-403.
20. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007;357:2237-2247.
21. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child 1994;71:251-253.
22. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: A retrospective analysis. J Pediatr Hematol Oncol 2003;25:660-664.